Share
 
Title
Code
Session Type
Channel
Date Time
Co-Chairs:

OA15.01 Heterologous vaccination with DNA and two different poxvirus vectors, expressing HIV-1 envelope on the surface of Gag virus-like particles, elicit autologous Tier 2 neutralising antibodies
Rosamund CHAPMAN, University of Cape Town, South Africa
Abstract
OA15.02 In vitro and in vivo analyses of HIV-1 clade C Envelope trimers highlight optimal antigenic profiles of novel HIV-1 Env-based vaccine candidates
Alexandra HAUSER, University of Regensburg, Germany
Abstract
OA15.03 Novel trimer-only (TO) producing HIV-1 envelope glycoprotein constructs for inducing broadly neutralizing antibody responses by genetic vaccination
Iván DEL MORAL SÁNCHEZ, Netherlands
Abstract
OA15.04 Structural Basis of Neutralizing Antibodies Targeting the CD4-Binding Site and Fusion Peptide Elicited by Immunization with Heterologous HIV-1 Env in NHP
Tongqing ZHOU, National Institute of Health, United States
Abstract
OA15.05LB Cross-reactivity between HIV-1 bnAbs and parasite glycans
Isabella HUETTNER, King's College London, United Kingdom
Abstract
OA15.06 Live Q&A